Drug
Maralixibat
Maralixibat: highest development phase Phase 3, developed by Mirum Pharmaceuticals, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Mirum Pharmaceuticals, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Maralixibat NCT06553768 | Phase 3 | Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC) |
Latest
No recent events.
Follow Maralixibat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.